July 12, 2021
Carey Featured in Video on Clinical Implications of the FeDeriCa trial in HER2+ Breast Cancer
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.